• SARS-CoV-2 N Protein Suppresses GADD34-Mediated Immunity via

  2026-06-19

  Liu et al. reveal that the SARS-CoV-2 nucleocapsid protein impairs the host's innate immune response by sequestering GADD34 mRNA into noncanonical cytoplasmic foci, thereby inhibiting type I interferon signaling. This mechanistic insight enhances understanding of SARS-CoV-2 immune evasion and offers new perspectives for antiviral strategy development.

• 1-myristoylglycerophosphocholine in Smooth Muscle and Fibros

  2026-06-19

  1-myristoylglycerophosphocholine (14:0 Lyso-PC) is a pivotal tool for dissecting lipid signaling in smooth muscle contraction and pulmonary fibrosis models. This guide details advanced protocols, troubleshooting strategies, and data-driven insights for leveraging this APExBIO reagent in cellular and physiological assays.

• DiR (DiIC 18 (7)) Enhances Membrane Imaging & Cell Tracking

  2026-06-18

  DiR (DiIC 18 (7)) stands out for robust, long-term cell membrane labeling in both live and fixed systems. Its near-infrared fluorescence, minimal cytotoxicity, and proven in vivo stability empower advanced cell tracking, neuronal tracing, and translational nanomedicine research.

• BMS-345541 Hydrochloride: Precision IKK Inhibition and Its I

  2026-06-18

  Explore how BMS-345541 hydrochloride, a selective IKK inhibitor, enables advanced dissection of apoptosis and necroptosis in inflammation and cancer biology research. This article uniquely bridges mechanistic insights from recent RIPK1 pathway discoveries with practical assay guidance.

• GSK343: EZH2 Inhibitor Workflows for Precision Epigenetic Re

  2026-06-17

  GSK343 stands out as a potent, selective EZH2 inhibitor that empowers cancer and stem cell researchers to dissect epigenetic mechanisms with confidence. This guide demystifies experimental design, troubleshooting, and advanced applications, drawing on cutting-edge findings to maximize reproducibility and insight.

• Biotin-16-UTP: Precision RNA Labeling for Interaction Studie

  2026-06-17

  Biotin-16-UTP enables highly specific, efficient RNA labeling for robust detection, purification, and interaction mapping. By integrating workflow optimization with the latest biomarker discovery research, this guide empowers molecular biologists to maximize data quality in RNA-protein studies and lncRNA assays.

• Cytochalasin D: Actin Polymerization Inhibitor for Advanced

  2026-06-16

  Cytochalasin D from APExBIO provides unparalleled control over actin dynamics, enabling precise dissection of cytoskeletal, cell cycle, and nanoparticle uptake mechanisms. This article bridges validated protocol enhancements, troubleshooting strategies, and innovative use-cases—especially in ocular drug delivery research.

• ALDOB K87 Lactylation Regulates Mitochondrial Dynamics in PH

  2026-06-16

  Yi et al. (2026) identify ALDOB K87 lactylation as a pivotal regulator of mitochondrial fission and metabolic reprogramming in pulmonary hypertension. Their work bridges metabolic remodeling to abnormal smooth muscle cell behavior, highlighting new therapeutic targets for pulmonary vascular disease.

• Novel PDK4 Inhibitors for Metabolic Disease: Mechanistic Ins

  2026-06-15

  This study identifies a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, exemplified by compound 8c, with potent effects on glucose tolerance, allergic response, and cancer cell behavior. The findings provide a strong rationale for targeting PDK4 in metabolic and immune-mediated diseases, advancing therapeutic strategies for conditions such as diabetes and allergy.

• Computational Fluorescent Biosensing for Amatoxin Detection

  2026-06-15

  The reference study presents a novel computationally aided strategy to design haptens and monoclonal antibodies for simultaneous, highly sensitive detection of amatoxins and phallotoxins in mushrooms. This dual-target fluorescent immunochromatographic assay offers a practical advance for rapid on-site screening, directly addressing public health risks from mushroom poisoning.

• 3-Methyladenine in Applied Autophagy Research: Protocols & P

  2026-06-14

  3-Methyladenine (3-MA) empowers targeted modulation of autophagy in complex models, offering precise PI3K inhibition and robust experimental control. This article distills advanced workflows, troubleshooting strategies, and comparative insights for maximizing the value of APExBIO’s 3-MA in autophagy and cancer research.

• Verbascoside as a PKC/NF-κB Inhibitor: Protocols and Pitfall

  2026-06-13

  Verbascoside stands out as a potent PKC/NF-κB inhibitor with robust assay reproducibility, especially in osteoclastogenesis and neuroinflammation models. This article provides actionable protocol enhancements, troubleshooting strategies, and unique translational insights from recent microglial research.

• Sumatriptan's Anti-Inflammatory Actions: Systematic Review I

  2026-06-12

  Ala et al.'s systematic review rigorously evaluates sumatriptan's emerging anti-inflammatory properties, extending its relevance beyond migraine management. The work synthesizes evidence for sumatriptan's modulation of key inflammatory mediators and highlights its translational potential for diverse inflammatory models.

• Applied ROS Detection: Reactive Oxygen Species Assay Kit (DH

  2026-06-12

  Harness the power of precise intracellular superoxide measurement with the Reactive Oxygen Species Assay Kit (DHE) from APExBIO. Discover advanced workflow enhancements, troubleshooting insights, and translational research strategies that elevate oxidative stress and apoptosis studies.

• XPO1 Inhibition Sensitizes GCB-DLBCL to Platinum Chemotherap

  2026-06-11

  The referenced study demonstrates that inhibiting XPO1 markedly enhances the sensitivity of germinal-center B-cell-like diffuse large B-cell lymphoma (GCB-DLBCL) cells to platinum-based chemotherapies. This finding provides a mechanistic rationale for combining XPO1 inhibitors such as Selinexor with platinum agents as a potential salvage therapy for refractory DLBCL.

16909 records 1/1128 page Next 12345 下5页 Last page